Endocannabinoid System & Athlete Mental Health Research Insights
Mental health outcomes retired athletes face are shaped by complex factors including brain trauma and identity loss. Research on the endocannabinoid system offers insights into these challenges. This article reviews key findings on mental health outcomes…
Cannabinoid Clinical Trials for Anxiety and Tourette Syndrome
Effects of cannabinoid formulations on anxiety have been studied across multiple clinical trials, showing measurable symptom reductions. CBD and THC compounds demonstrate varying efficacy depending on formulation and condition. Evidence for Tourette…
Endocannabinoid System & CBD for Autism: RCT Evidence
This randomized controlled trial investigates the effects of cannabidiol on autism anxiety and social relating in children aged 5 to 12. The study shows potential benefits of CBD in reducing anxiety and parental stress. These findings provide important…
Johns Hopkins Study Reveals Cannabis Mental Health Risks
The Johns Hopkins cannabis mental health risks study identifies heightened psychiatric concerns linked to recreational cannabis legalization. This research highlights vulnerable populations facing increased mental health risks. Clinicians should consider…
IGC Pharma Nears Completion of Phase 2 CALMA Trial Enrollment
The phase 2 CALMA trial enrollment by IGC Pharma has reached 80%, marking significant progress in cannabis-derived therapeutic research. This trial aims to establish safety and efficacy data for a novel cannabis pharmaceutical candidate. Clinicians…
Weekly Roundup Cannabis Psychedelic Sector – April 13, 2026
This weekly roundup cannabis psychedelic sector review covers the latest industry developments and research findings. Clinicians and patients can stay informed on regulatory and market trends. The April 13, 2026 edition highlights key cannabis and…
Review Finds Limited Evidence for Cannabis in Treating Mental Health Disorders
A recent review highlights limited evidence cannabis mental health benefits for conditions like PTSD and anxiety. The study emphasizes the need for more rigorous research. Clinicians should consider cannabis as adjunctive, not primary, therapy.
CBD for Calm: How to Use It in Real Life (Timing, Format & What to Expect)
CBD dosing anxiety treatment is a common patient inquiry in cannabis medicine. Clear, evidence-based guidance helps clinicians counsel patients effectively. Understanding dosing protocols and realistic expectations is key to using CBD for calm.
Daily Anxiety and Depressive Symptoms Linked to Cannabis-Alcohol Co-Use
Daily anxiety cannabis alcohol co-use is strongly linked to mental health symptoms among Black sexual and gender minority people. This study highlights the increased risk of same-day co-use compared to single-substance use. Understanding these patterns…
Managing Stress in College: What Students Are Turning to for Relief
College students are increasingly exploring various stress management preferences, including cannabis use, to relieve anxiety and improve mental health. Understanding these preferences helps inform preventive care and early intervention strategies.…
